Annual EPS
-$13.76
+$11.10+44.65%
31 December 2023
Summary:
Spyre Therapeutics annual earnings per share is currently -$13.76, with the most recent change of +$11.10 (+44.65%) on 31 December 2023. During the last 3 years, it has risen by +$11.26 (+45.00%). SYRE annual EPS is now at all-time high.SYRE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.06
-$0.47-79.66%
30 September 2024
Summary:
Spyre Therapeutics quarterly earnings per share is currently -$1.06, with the most recent change of -$0.47 (-79.66%) on 30 September 2024. Over the past year, it has dropped by -$0.20 (-23.26%). SYRE quarterly EPS is now -79.66% below its all-time high of -$0.59, reached on 30 June 2024.SYRE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$4.12
-$0.20-5.10%
30 September 2024
Summary:
Spyre Therapeutics TTM earnings per share is currently -$4.12, with the most recent change of -$0.20 (-5.10%) on 30 September 2024. Over the past year, it has increased by +$46.46 (+91.85%). SYRE TTM EPS is now -5.10% below its all-time high of -$3.92, reached on 30 June 2024.SYRE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.6% | -23.3% | +91.8% |
| 3 y3 years | +45.0% | +86.4% | +83.5% |
| 5 y5 years | +77.5% | +93.5% | +93.3% |
SYRE EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.0% | -79.7% | +97.4% | -5.1% | +92.4% |
| 5 y | 5 years | at high | +77.5% | -79.7% | +97.4% | -5.1% | +93.3% |
| alltime | all time | at high | +77.5% | -79.7% | +97.4% | -5.1% | +93.3% |
Spyre Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.06(+79.7%) | -$4.12(+5.1%) |
| June 2024 | - | -$0.59(-18.1%) | -$3.92(-91.0%) |
| Mar 2024 | - | -$0.72(-58.9%) | -$43.47(-8.8%) |
| Dec 2023 | -$13.76(-44.7%) | -$1.75(+103.7%) | -$47.64(-5.8%) |
| Sept 2023 | - | -$0.86(-97.9%) | -$50.58(-7.3%) |
| June 2023 | - | -$40.14(+720.9%) | -$54.56(+157.7%) |
| Mar 2023 | - | -$4.89(+4.3%) | -$21.17(-17.1%) |
| Dec 2022 | -$24.86(-0.6%) | - | - |
| Dec 2022 | - | -$4.69(-3.1%) | -$25.53(-10.8%) |
| Sept 2022 | - | -$4.84(-28.3%) | -$28.61(-9.2%) |
| June 2022 | - | -$6.75(-27.0%) | -$31.52(+15.6%) |
| Mar 2022 | - | -$9.25(+19.0%) | -$27.27(+9.0%) |
| Dec 2021 | -$25.02(-34.2%) | -$7.77(+0.3%) | -$25.02(-2.8%) |
| Sept 2021 | - | -$7.75(+210.0%) | -$25.75(+2.0%) |
| June 2021 | - | -$2.50(-64.3%) | -$25.25(-22.9%) |
| Mar 2021 | - | -$7.00(-17.6%) | -$32.75(-18.1%) |
| Dec 2020 | -$38.00(-38.0%) | -$8.50(+17.2%) | -$40.00(-16.2%) |
| Sept 2020 | - | -$7.25(-27.5%) | -$47.75(-16.2%) |
| June 2020 | - | -$10.00(-29.8%) | -$57.00(-6.2%) |
| Mar 2020 | - | -$14.25(-12.3%) | -$60.75(-0.8%) |
| Dec 2019 | -$61.25 | -$16.25(-1.5%) | -$61.25(+0.4%) |
| Sept 2019 | - | -$16.50(+20.0%) | -$61.00(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$13.75(-6.8%) | -$58.00(+4.0%) |
| Mar 2019 | - | -$14.75(-7.8%) | -$55.75(+4.7%) |
| Dec 2018 | -$53.25(+18.3%) | -$16.00(+18.5%) | -$53.25(+13.9%) |
| Sept 2018 | - | -$13.50(+17.4%) | -$46.75(+3.3%) |
| June 2018 | - | -$11.50(-6.1%) | -$45.25(-0.5%) |
| Mar 2018 | - | -$12.25(+28.9%) | -$45.50(+1.1%) |
| Dec 2017 | -$45.00(-18.9%) | -$9.50(-20.8%) | -$45.00(+2.9%) |
| Sept 2017 | - | -$12.00(+2.1%) | -$43.75(+0.6%) |
| June 2017 | - | -$11.75(0.0%) | -$43.50(+0.6%) |
| Mar 2017 | - | -$11.75(+42.4%) | -$43.25(+4.4%) |
| Dec 2016 | -$55.50(+120.2%) | -$8.25(-29.8%) | -$41.45(-1.1%) |
| Sept 2016 | - | -$11.75(+2.2%) | -$41.92(-1.8%) |
| June 2016 | - | -$11.50(+15.6%) | -$42.68(+17.2%) |
| Mar 2016 | - | -$9.95(+14.0%) | -$36.41(+0.2%) |
| Dec 2015 | -$25.20(-33.5%) | -$8.72(-30.3%) | -$36.35(-7.5%) |
| Sept 2015 | - | -$12.51(+139.2%) | -$39.29(+1.5%) |
| June 2015 | - | -$5.23(-47.1%) | -$38.69(-8.4%) |
| Mar 2015 | - | -$9.88(-15.2%) | -$42.24(+11.4%) |
| Dec 2014 | -$37.93 | -$11.66(-2.1%) | -$37.93(+44.4%) |
| Sept 2014 | - | -$11.91(+35.6%) | -$26.27(+83.0%) |
| June 2014 | - | -$8.78(+57.6%) | -$14.35(+157.6%) |
| Mar 2014 | - | -$5.57 | -$5.57 |
FAQ
- What is Spyre Therapeutics annual earnings per share?
- What is the all time high annual EPS for Spyre Therapeutics?
- What is Spyre Therapeutics annual EPS year-on-year change?
- What is Spyre Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly EPS year-on-year change?
- What is Spyre Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Spyre Therapeutics?
- What is Spyre Therapeutics TTM EPS year-on-year change?
What is Spyre Therapeutics annual earnings per share?
The current annual EPS of SYRE is -$13.76
What is the all time high annual EPS for Spyre Therapeutics?
Spyre Therapeutics all-time high annual earnings per share is -$13.76
What is Spyre Therapeutics annual EPS year-on-year change?
Over the past year, SYRE annual earnings per share has changed by +$11.10 (+44.65%)
What is Spyre Therapeutics quarterly earnings per share?
The current quarterly EPS of SYRE is -$1.06
What is the all time high quarterly EPS for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly earnings per share is -$0.59
What is Spyre Therapeutics quarterly EPS year-on-year change?
Over the past year, SYRE quarterly earnings per share has changed by -$0.20 (-23.26%)
What is Spyre Therapeutics TTM earnings per share?
The current TTM EPS of SYRE is -$4.12
What is the all time high TTM EPS for Spyre Therapeutics?
Spyre Therapeutics all-time high TTM earnings per share is -$3.92
What is Spyre Therapeutics TTM EPS year-on-year change?
Over the past year, SYRE TTM earnings per share has changed by +$46.46 (+91.85%)